EOSINOPHILIC NEUROTOXIN AS A CLINICAL BIOMARKER FOR EVALUATION OF THE ACTIVITY OF ATOPIC DISEASES

  • Ю С Карпеева Saint-Petersburg State Pediatric Medical University, 194100, Saint-Petersburg, Litovskaya str., 2
Keywords: eosinophilic neurotoxin, bronchial asthma, atopic disease, eosinophilic esophagitis, biomarkers of the disease

Abstract

Eosinophilic neurotoxin is considered as a biomarker for the diagnosis of eosinophilic diseases with the prospect of using to monitor the dynamics of treatment of bronchial asthma and eosinophilic lesions of the gastrointestinal tract

Published
2019-03-14
How to Cite
Карпеева, Ю. С. (2019). EOSINOPHILIC NEUROTOXIN AS A CLINICAL BIOMARKER FOR EVALUATION OF THE ACTIVITY OF ATOPIC DISEASES. Medicine: Theory and Practice, 3(3 приложен), 81-83. Retrieved from https://ojs3.gpmu.org/index.php/med-theory-and-practice/article/view/349
Issue
Vol 3 No 3 приложен (2018)
Section
Статьи